首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Diabetes & vascular disease research

缩写:

ISSN:1479-1641

e-ISSN:1752-8984

IF/分区:3.0/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引812
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Laura Venskutonyte,Lars Rydén,Göran Nilsson et al. Laura Venskutonyte et al.
Objective: Hyperglycaemia enhances the risk of cardiovascular events and death, while high-density lipoprotein cholesterol (HDLc) is protective. Information on these associations among the elderly population is scanty. We...
Gopalakrishnan Ramakrishnan,Albina Arjuman,Shilpa Suneja et al. Gopalakrishnan Ramakrishnan et al.
The insulin receptor (IR) and low-density lipoprotein receptor (LDLR) maintain glucose and lipid metabolism, respectively. Diabetes is associated with increased blood glucose, dyslipidaemia and increased risk of atherosclerosis. We hypothes...
Joanna-Marie Howes,Victoria R Richardson,Kerrie A Smith et al. Joanna-Marie Howes et al.
Background and method: Increased plasma clot density and prolonged lysis times are associated with cardiovascular disease. In this study, we employed a functional proteomics approach to identify novel clot components whic...
David Rosenbaum,Boris Hansel,Dominique Bonnefont-Rousselot et al. David Rosenbaum et al.
Purpose: Our aim was to determine the influence of waist circumference on the repartition of high-density lipoprotein (HDL) and low-density lipoprotein (LDL) subfractions in patients with increased waist perimeter and one...
Pamela B DeGuzman,Kwame O Akosah,Allan G Simpson et al. Pamela B DeGuzman et al.
Guidelines recommend aggressive goals for lipid and blood pressure reduction for high risk patients with diabetes mellitus and atherosclerotic coronary disease. However, it remains unclear how many patients achieve treatment goals versus th...
Thor Ueland,Pål Aukrust,Svend Aakhus et al. Thor Ueland et al.
Background: Silent coronary artery disease is a frequent complication of type 2 diabetes (T2DM). Based on its multiple roles in inflammation, atherogenesis and glucose homeostasis, we hypothesised that activin A could be ...
Michel Farnier,Kjetil Retterstøl,Armin Steinmetz et al. Michel Farnier et al.
Background: This study was designed to compare the efficacy and safety of a fenofibrate/pravastatin 160/40 mg fixed-dose combination plus ezetimibe 10 mg triple therapy and simvastatin 20 mg plus ezetimibe 10 mg dual ther...
Suman Tandon,Frans J T Wackers,Silvio E Inzucchi et al. Suman Tandon et al.
Gender differences in cardiovascular outcomes were compared in asymptomatic men and women with type 2 diabetes (T2DM) in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study. Of 1123 participants, 290 men and 271 women were rand...
S N Goyal,S Bharti,B Krishnamurthy et al. S N Goyal et al.
Metabolic syndrome (MetS) is defined as a cluster of numerous cardiovascular risk factors, which encompasses obesity, dyslipidaemia, insulin resistance and hypertension. Patients with MetS are more prone to developing cardiovascular events ...
Gael Bories,Robert Caiazzo,Bruno Derudas et al. Gael Bories et al.
Visceral obesity is a chronic, low-grade inflammatory disease that predisposes people to the metabolic syndrome, type 2 diabetes and its cardiovascular complications. Adipose tissue is not a passive storehouse for fat, but an endocrine orga...